JP2005500390A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500390A5
JP2005500390A5 JP2003521814A JP2003521814A JP2005500390A5 JP 2005500390 A5 JP2005500390 A5 JP 2005500390A5 JP 2003521814 A JP2003521814 A JP 2003521814A JP 2003521814 A JP2003521814 A JP 2003521814A JP 2005500390 A5 JP2005500390 A5 JP 2005500390A5
Authority
JP
Japan
Prior art keywords
kgf
pharmaceutical composition
amino acid
composition according
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003521814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500390A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/026929 external-priority patent/WO2003016505A2/en
Publication of JP2005500390A publication Critical patent/JP2005500390A/ja
Publication of JP2005500390A5 publication Critical patent/JP2005500390A5/ja
Pending legal-status Critical Current

Links

JP2003521814A 2001-08-21 2002-08-21 Ｋｇｆポリペプチド組成物 Pending JP2005500390A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31388101P 2001-08-21 2001-08-21
PCT/US2002/026929 WO2003016505A2 (en) 2001-08-21 2002-08-21 Kgf polypeptide compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009119866A Division JP2009221207A (ja) 2001-08-21 2009-05-18 Ｋｇｆポリペプチド組成物

Publications (2)

Publication Number Publication Date
JP2005500390A JP2005500390A (ja) 2005-01-06
JP2005500390A5 true JP2005500390A5 (https=) 2006-01-05

Family

ID=23217561

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003521814A Pending JP2005500390A (ja) 2001-08-21 2002-08-21 Ｋｇｆポリペプチド組成物
JP2009119866A Withdrawn JP2009221207A (ja) 2001-08-21 2009-05-18 Ｋｇｆポリペプチド組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009119866A Withdrawn JP2009221207A (ja) 2001-08-21 2009-05-18 Ｋｇｆポリペプチド組成物

Country Status (8)

Country Link
US (2) US7265089B2 (https=)
EP (1) EP1429799A4 (https=)
JP (2) JP2005500390A (https=)
AU (1) AU2002326742B2 (https=)
CA (1) CA2457781A1 (https=)
MX (1) MXPA04001526A (https=)
PL (1) PL374269A1 (https=)
WO (1) WO2003016505A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011008904A1 (en) 2009-07-17 2011-01-20 Tabor Aaron T Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
RU2016117275A (ru) 2013-11-01 2017-12-04 Сфериум Биомед С.Л. Тельца включения для трансдермальной доставки терапевтических и косметических средств
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
CN109402130A (zh) * 2018-11-23 2019-03-01 成都中医药大学附属医院 一种重组人角质细胞生长因子-1及其制备方法和用途
KR20230127721A (ko) * 2022-02-25 2023-09-01 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2250213C2 (ru) 1989-01-31 2005-04-20 Джеффри С. РУБИН Выделенный белок фактора роста кератиноцита (kgf), рекомбинантная молекула днк, вектор, способ конструирования клетки-хозяина, способ получения белка, фармацевтическая композиция
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5655870A (en) * 1993-03-01 1997-08-12 Kawasaki Steel Corporation Stacker crane in a warehouse
US5814605A (en) 1993-03-26 1998-09-29 Amgen Inc. Therapeutic uses of keratinocyte growth factor
CA2166278A1 (en) * 1993-06-29 1995-01-12 Denis J. Gospodarowicz A truncated keratinocyte growth factor (kgf) having increased biological activity
SI0785950T1 (en) 1994-10-13 2003-08-31 Amgen Inc. Keratinocyte growth factor analogs
SI0785949T1 (en) * 1994-10-13 2003-08-31 Amgen Inc. Method for purifying keratinocyte growth factors
WO1996011949A2 (en) * 1994-10-13 1996-04-25 Amgen Inc. Analogs of keratinocyte growth factor
US5841605A (en) * 1996-11-06 1998-11-24 Iomega Corporation Caddy for cartridge and disk drive accomodating a caddy
EP1012186B1 (en) 1996-12-06 2002-07-17 Amgen Inc., Use of a kgf protein product(s) and a glp-2 protein product(s) for the preparation of a medicament

Similar Documents

Publication Publication Date Title
JP2001520238A5 (https=)
RU95113418A (ru) Полипептиды, способы получения, днк, вектор, клетка, применение полипептида, фармацевтические композиции
JP2004536077A5 (https=)
CA2308116A1 (en) Low-toxicity human interferon-alpha analog
JP2008507298A5 (https=)
DE60125381D1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
HRP20110242T1 (hr) Formulacija s fuzijskim proteinom glp-1-fc
EP0651765A1 (en) Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis
HRP20140616T1 (hr) Peptidni analog oksintomodulina
JP2009525052A5 (https=)
JP2002528060A5 (https=)
RU2007110981A (ru) Урокортин iii и его использование
JP2010507391A (ja) 組織傷害の修復におけるストロマ細胞由来因子１のプロテアーゼ耐性変異体
DK165988B (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
JP2006506942A5 (https=)
JP2004531242A5 (https=)
JP2012508698A5 (https=)
JP2007535910A5 (https=)
JP2005500390A5 (https=)
JP2004513079A5 (https=)
JP2004532037A5 (https=)
JPH03504501A (ja) 両親媒性ペプチドとその用途
JP2007536910A5 (https=)
JP2004533846A5 (https=)
JP2021531246A5 (https=)